A Sos‐derived peptidimer blocks the Ras signaling pathway by binding both Grb2 SH3 domains and displays antiproliferative activity
- 1 January 1999
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 13 (1) , 31-39
- https://doi.org/10.1096/fasebj.13.1.31
Abstract
With the aim of interrupting the growth factor-stimulated Ras signaling pathway at the level of the Grb2–Sos interaction, a peptidimer, made of two identical proline-rich sequences from Sos linked by a lysine spacer, was designed using structural data from Grb2 and a proline-rich peptide complexed with its SH3 domains. The peptidimer affinity for Grb2 is 40 nM whereas that of the monomer is 16 μM, supporting the dual recognition of both Grb2 SH3 domains by the dimer. At 50 nM, the peptidimer blocks selectively Grb2–Sos complexation in ER 22 (CCL 39 fibroblasts overexpressing epidermal growth factor receptor) cellular extracts. The peptidimer specifically recognizes Grb2 and does not interact with PI3K or Nck, two SH3 domain-containing adaptors. The peptidimer was modified to enter cells by coupling to a fragment of Antennapedia homeodomain. At 10 μM, the conjugate inhibits the Grb2–Sos interaction (100%) and MAP kinase (ERK1 and ERK2) phosphorylation (60%) without modifying cellular growth of ER 22 cells. At the same concentration, the conjugate also inhibits both MAP kinase activation induced by nerve growth factor or epidermal growth factor in PC12 cells, and differentiation triggered by nerve growth factor. Finally, when tested for its antiproliferative activity, the conjugate was an efficient inhibitor of the colony formation of transformed NIH3T3/HER2 cells grown in soft agar, with an IC50 of around 1 μM. Thus, the designed peptidimers appear to be interesting leads to investigate signaling and intracellular processes and for designing selective inhibitors of tumorigenic Ras-dependent processes.—Cussac, D., Vidal, M., LePrince, C., Liu, W.-Q., Cornille, F., Tiraboschi, G., Roques, B. P., Garbay, C. A Sos-derived peptidimer blocks the Ras signaling pathway by binding both Grb2 SH3 domains and displays antiproliferative activity. FASEB J. 13, 31–38 (1999)Keywords
This publication has 55 references indexed in Scilit:
- Exploring the Leucine-Proline Binding Pocket of the Src SH3 Domain Using Structure-Based, Split-Pool Synthesis and Affinity-Based SelectionJournal of the American Chemical Society, 1998
- Solution structure of the Grb2 N-terminal SH3 domain complexed with a ten-residue peptide derived from SOS: direct refinement against NOEs, J-couplings and 1H and 13C chemical shiftsJournal of Molecular Biology, 1997
- Gastrin induces tyrosine phosphorylation of Shc proteins and their association with the Grb2/Sos complexFEBS Letters, 1996
- Crystal Structure of the Mammalian Grb2 AdaptorScience, 1995
- Identification of a Ten-Amino Acid Proline-Rich SH3 Binding SiteScience, 1993
- Incorporation of new amphiphilic perfluoroalkylated bipyridine platinum and palladium complexes into liposomes: stability and structure-incorporation relationshipsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- NGF and EGF rapidly activate p21ras in PC12 cells by distinct, convergent pathways involving tyrosine phosphorylationNeuron, 1991
- Microtubule‐associated‐protein (MAP) kinase activated by nerve growth factor and epidermal growth factor in PC12 cellsEuropean Journal of Biochemistry, 1990
- DNA polyintercalation: comparison of DNA binding properties of an acridine dimer and trimerFEBS Letters, 1984
- Solid Phase Peptide Synthesis. I. The Synthesis of a TetrapeptideJournal of the American Chemical Society, 1963